Comparison of effects of tacrolimus ointment and mometasone furoate cream on the epidermal barrier of patients with atopic dermatitis;Vergleich der Effekte von Tacrolimus-Salbe und Mometasonfuroat-Fettcreme auf die epidermale Barriere bei Patienten mit atopischem Ekzem unter reaktiver Therapie

JDDG - Journal of the German Society of Dermatology

Volumn 11, Issue 5, 2013, Pages 437-443

  Dähnhardt Pfeiffer, Stephan ^a   Dähnhardt, Dorothee ^a   Buchner, Matthias ^b   Walter, Kersten ^c   Proksch, Ehrhardt ^b   Fölster Holst, Regina ^b  

^a Microscopy Services Dähnhardt GmbH   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c Astellas Pharma GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; MOMETASONE FUROATE; TACROLIMUS;

ADULT; ATOPIC DERMATITIS; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CREAM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; FEMALE; FOREARM; HUMAN; HYDRATION; INTERCELLULAR SPACE; MALE; MEASUREMENT; OINTMENT; OPEN STUDY; QUANTITATIVE ANALYSIS; REVIEW; SKIN; STRATUM CORNEUM; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT DURATION;

EID: 84877104477     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/ddg.12074     Document Type: Review

References (20)

1. Madison KC,. Barrier function of the skin: "La raison d'Etre "of the epidermis. J Invest Dermatol 2003; 121 (2): 231-41.
2. Proksch E, Fölster-Holst R, Bräutigam M, et al. Die Rolle der epidermalen Barriere beim atopischen Ekzem. J Dtsch Dermatol Ges 2009; 7: 899-911.
3. Fölster-Holst R, Dähnhardt-Pfeiffer S, Dähnhardt D, Proksch E,. The role of skin barrier function in atopic dermatitis (an update). Expert Rev Dermatol 2012; 7 (3): 247-58.
4. Cork MJ, Danby SG, Vasilopoulos Y, et al. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol 2009; 129: 1892-908.
5. Elias PM,. Epidermal lipids, barrier function, and desquamation. J Invest Dermatol 1983; 80: 044s-049s.
6. Proksch E, Jensen JM, Elias P,. Skin lipids and epidermal differentiation on atopic dermatitis. Clin Dermatol 2003; 21: 134-44.
7. Chamlin SL, Kao J, Frieden IJ, et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: Changes in barrier function provide a sensitive indicator of disease activity. Am Acad Dermatol 2002; 47: 198-208.
8. Danby SG, Cork MJ,. A new understanding of atopic dermatitis: the role of epidermal barrier dysfunction and subclinical inflammation. Derma 2010; 1 (2): 33-46.
9. Darsow U, Wollenberg A, Simon D, et al. ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. JEADV 2010; 24: 317-28.
10. Ring J, Alomar A, Bieber T, et al. Guidelines for treatment of atopic eczema (atopicdermatitis) part I. J Eur Acad Dermatol Venereol 2012; 26 (8): 1045-60.
11. Leitlinie der Deutschen Dermatologischen Gesellschaft (DDG). Topische Therapie mit Glukokortikoiden. AWMF-Leitlinien-Register, Nr. 013/034.
12. Hengge UR, Ruzicka T, Schwartz RA, Cork MJ,. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol 2006; 54: 1-15.
13. Fachinformation Protopic®, Stand Juni 2011.
14. Leitlinien der Deutschen Dermatologischen Gesellschaft (DDG) und des Berufsverbandes Deutscher Dermatologen (BVDD). Therapie des atopischen Ekzems mit Calcineurin-Inhibitoren. AWMF-Leitlinien-Register, Nr. 013/037.
15. Reitamo S, Rustin M, Ruzicka T, et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol 2002; 109: 547-55.
16. Daehnhardt-Pfeiffer S, Surber C, Wilhelm KP, et al. Noninvasive stratum corneum sampling and electron microscopical examination of skin barrier integrity: pilot study with a topical glycerin formulation for atopic dermatitis. Skin Pharmacol Physiol 2012; 25: 155-61.
17. Schnopp C, Remling R, Möhrenschlager M, et al. Topical tacrolimus (FK506) and mometasonefuroate in treatment of dyshidrotic palmar eczema: A randomized, observer-blinded trial. J Am Acad Dermatol 2002; 46 (1): 73-7.
18. Jensen JM, Pfeiffer S, Witt M, et al. Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis. J Allergy Clin Immunol 2009; 123 (5): 1124-33.
19. Lodén M,. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol 2003; 4 (11): 771-88.
20. Kim M, Jung M, Hong SP, et al. Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function. Exp Dermatol 2010; 19: 501-10.